EntrepreneurialCheck
Mark Yarchoan estimated net worth profile

Mark Yarchoan net worth

Mark Yarchoan Net Worth 2026 (Estimated) · Founder at Adventris Pharmaceuticals · YC W23
est. wealth $6.67M

Quick answer

Mark Yarchoan's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Mark Yarchoan is Founder at Adventris Pharmaceuticals. Adventris Pharmaceuticals valuation.

Mark Yarchoan is Founder at Adventris Pharmaceuticals (YC W23). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameMark Yarchoan
RoleFounder
CompanyAdventris Pharmaceuticals
YC batchW23
Est. company val$20.0M
Assumed ownership33.3%
Est. paper wealth / net worth$6.67M
$4.67M – $10.0M
  • Company status: Active
  • Education: University of Pennsylvania
  • Region: United States of America
  • Industries: Healthcare, Drug Discovery and Delivery
  • Team size: 7
  • Website: https://adventris.com

Who is Mark Yarchoan?

Mark Yarchoan is a founder involved with Adventris Pharmaceuticals and has participated in Y Combinator's Winter 2023 batch.

Highlights:

  • University of Pennsylvania
  • Adventris Pharmaceuticals
  • Y Combinator W23

About Adventris Pharmaceuticals

Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.

If you are interested in learning more about our approach to treat and prevent...

FAQ: Mark Yarchoan net worth and Adventris Pharmaceuticals valuation

What is Mark Yarchoan's net worth?

Mark Yarchoan's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Mark Yarchoan is Founder at Adventris Pharmaceuticals. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Adventris Pharmaceuticals valuation?

Adventris Pharmaceuticals's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Mark Yarchoan's role?

Mark Yarchoan is Founder at Adventris Pharmaceuticals, a Y Combinator-backed startup (batch W23).